Valuation: HeartSciences Inc.

Market Cap 9.89M 9.02M 8.34M 7.52M 14.17M 924M 14.73M 101M 39.81M 499M 37.1M 36.32M 1.57B P/E 2027 *
-0.72x
P/E 2028 * -1.02x
Enterprise Value 9.89M 9.02M 8.34M 7.52M 14.17M 924M 14.73M 101M 39.81M 499M 37.1M 36.32M 1.57B EV / Sales 2027 *
578x
EV / Sales 2028 * 3.14x
Free-Float
80.02%
Yield 2027 *
-
Yield 2028 * -
1 day+1.94%
1 week-8.50%
Current month-36.56%
1 month-31.60%
3 months-1.41%
6 months+12.90%
Current year-32.04%
1 week 2
Extreme 2
2.34
1 month 2
Extreme 2
3.68
Current year 1.63
Extreme 1.63
5.25
1 year 1.63
Extreme 1.63
5.25
3 years 1.63
Extreme 1.63
29
5 years 1.63
Extreme 1.63
600
10 years 1.63
Extreme 1.63
600
Manager TitleAgeSince
Chief Executive Officer 57 01/03/2022
Director of Finance/CFO 44 01/04/2022
Chief Tech/Sci/R&D Officer - 01/07/2014
Director TitleAgeSince
Chairman 57 01/06/2013
Director/Board Member 54 01/01/2014
Director/Board Member 70 01/05/2020
Date Insider Type Main position Quantity % Market Cap. Importance
7/7/26 A Free

Chief Financial Officer

25,000 0.7598%
1/12/26 A Free

Director

15,000 0.4720%
1/12/26 A Free

Director

15,000 0.4720%
Change 5-day change 1-year change 3-year change Capi.($)
+1.94%-8.50%-30.69%-88.65% 9.89M
+0.87%-3.48%+20.26%+47.70% 254B
+1.24%-2.86%+1.36%+8.32% 159B
-2.23%-6.36%-23.01%+35.21% 149B
+1.42%-3.30%-56.02%-19.87% 62.37B
-0.19%-0.55%+25.21%+56.62% 60.62B
+1.25%+2.10%+4.93%-12.39% 53.05B
+2.97%+0.21%+23.28%+55.58% 48.55B
-3.89%-9.05%+1.27%+55.11% 46.7B
+3.63%-1.02%+23.76%+78.63% 44.21B
Average +0.80%-4.45%-0.96%+21.62% 88B
Weighted average by Cap. +0.56%-3.00%+2.82%+33.02%

Financials

2027 *2028 *
Net sales 17.1K 15.6K 14.42K 13.01K 24.51K 1.6M 25.47K 174K 68.84K 862K 64.15K 62.81K 2.72M 3.15M 2.87M 2.66M 2.4M 4.51M 294M 4.69M 32.08M 12.68M 159M 11.82M 11.57M 502M
Net income -12.32M -11.24M -10.39M -9.37M -17.66M -1.15B -18.35M -125M -49.59M -621M -46.22M -45.25M -1.96B -10.6M -9.66M -8.93M -8.06M -15.18M -990M -15.78M -108M -42.65M -534M -39.75M -38.92M -1.69B
Net Debt - -
Projected Income Statement - Annual - HeartSciences Inc.
Logo HeartSciences Inc.
HeartSciences Inc. is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. The Company has libraries of artificial intelligence-enhanced electrocardiography (AI-ECG) algorithms and is developing AI-ECG solutions to be made available on either a hardware- agnostic cloud-based platform or its proprietary MyoVista wavECG device, to help identify cardiovascular disease in any care setting worldwide in a manner to suit different care providers. Its first product candidate for FDA clearance, the MyoVista wavECG, or the MyoVista, is a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction, which has traditionally only been available through the use of cardiac imaging. The MyoVista also provides conventional ECG information in the same test. It delivers AI-ECG algorithms using existing ECG devices across a hospital or health system.
Employees
14
Date Price Change Volume
19/11/26 $2.100 +1.94% 15,659
17/11/26 $2.060 -0.96% 17,544
16/11/26 $2.080 -2.12% 29,846
13/11/26 $2.125 -5.97% 35,705
12/11/26 $2.260 -1.53% 86,306
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
2.060USD
Average target price
12.00USD
Spread / Average Target
+482.52%
  1. Stock Market
  2. Stocks
  3. HSCS Stock